Acalabrutinib
Obinutuzumab
(Update) Acalabrutinib in CLL and MCL
Zanubrutinib
Update Venetoclax in CLL
Leukemia & Lymphoma Society
JNCCN: How To Manage Cancer Care During COVID-19 Pandemic
NCCN Guidelines for Patients
Cancer.gov